Dermata Therapeutics (DRMA) Short Interest Ratio & Short Volume → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free DRMA Stock Alerts $0.38 +0.02 (+5.56%) (As of 05/13/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Dermata Therapeutics Short Interest DataCurrent Short Volume80,400 sharesPrevious Short Volume77,600 sharesChange Vs. Previous Month+3.61%Dollar Volume Sold Short$26,298.84Short Interest Ratio / Days to Cover0.7Last Record DateApril 30, 2024Outstanding Shares6,660,000 sharesFloat Size6,260,000 sharesShort Percent of Float1.28%Today's Trading Volume117,243 sharesAverage Trading Volume610,339 sharesToday's Volume Vs. Average19% Short Selling Dermata Therapeutics ? Sign up to receive the latest short interest report for Dermata Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDRMA Short Interest Over TimeDRMA Days to Cover Over TimeDRMA Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Dermata Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202480,400 shares $26,298.84 +3.6%1.3%0.7 $0.33 4/15/202477,600 shares $23,295.52 -23.8%1.2%0.5 $0.30 3/31/2024101,800 shares $41,819.44 +42.6%1.7%0.2 $0.41 3/15/202471,400 shares $28,417.20 -0.8%2.1%0.1 $0.40 2/29/202472,000 shares $33,048.00 -57.5%2.5%0.1 $0.46 2/15/2024169,500 shares $78,817.50 -39.3%6.0%0.2 $0.47 Get the Latest News and Ratings for DRMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024279,400 shares $137,045.70 -5.5%9.9%0.3 $0.49 1/15/2024295,600 shares $159,328.40 +1,032.6%10.5%0.3 $0.54 12/31/202326,100 shares $15,921.00 -25.9%0.9%0 $0.61 12/15/202335,200 shares $23,936.00 -67.7%1.3%0.2 $0.68 11/30/2023108,800 shares $81,099.52 +57.7%3.9%0.5 $0.75 11/15/202369,000 shares $44,988.00 +156.5%2.5%0.2 $0.65 10/31/202326,900 shares $15,653.11 -34.6%1.0%0.2 $0.58 10/15/202341,100 shares $30,825.00 -42.3%1.5%0.3 $0.75 9/30/202371,200 shares $75,472.00 -29.1%2.6%0.5 $1.06 9/15/2023100,400 shares $117,468.00 +16,633.3%3.6%0.6 $1.17 8/31/2023600 shares $744.00 -95.8%0.0%0 $1.24 8/15/202314,400 shares $16,992.00 -10.0%0.5%0.1 $1.18 7/31/202316,000 shares $20,800.00 -66.3%0.8%0 $1.30 7/15/202347,500 shares $74,575.00 -42.5%2.3%0.1 $1.57 6/30/202382,600 shares $136,290.00 +17.5%4.0%0 $1.65 6/15/202370,300 shares $130,055.00 +221.0%3.6%0 $1.85 5/31/202321,900 shares $35,040.00 -68.5%1.7%0 $1.60 5/15/202369,600 shares $179,568.00 +10.3%4.1%0 $2.58 4/30/202363,100 shares $103,484.00 +248.6%0.7%0 $1.64 4/15/202318,100 shares $22,806.00 -40.9%0.2%0 $1.26 3/31/202330,600 shares $39,474.00 +155.0%0.4%0 $1.29 3/15/202312,000 shares $33,840.00 -93.8%0.2%0 $2.82 2/28/2023194,000 shares $50,440.00 -0.2%2.4%0.1 $0.26 2/15/2023194,400 shares $56,084.40 -42.2%2.4%0.1 $0.29 1/31/2023336,100 shares $92,057.79 +36.2%4.2%0.2 $0.27 1/15/2023246,800 shares $67,277.68 +121.0%3.1%0.1 $0.27 12/30/2022111,700 shares $45,685.30 -5.7%1.4%0.1 $0.41 12/15/2022118,500 shares $23,024.55 +8.2%1.5%0.2 $0.19 11/30/2022109,500 shares $70,616.55 -25.8%1.5%0.4 $0.64 11/15/2022147,600 shares $98,892.00 -18.6%2.1%0.6 $0.67 10/31/2022181,300 shares $119,748.65 +129.5%3.0%0.5 $0.66 10/15/202279,000 shares $56,090.00 +62.6%1.3%0.2 $0.71 9/30/202248,600 shares $25,276.86 +21.5%0.8%0.1 $0.52 9/15/202240,000 shares $25,672.00 -54.3%0.7%0 $0.64Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. DRMA Short Interest - Frequently Asked Questions What is Dermata Therapeutics' current short interest? Short interest is the volume of Dermata Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 80,400 shares of DRMA short. 1.28% of Dermata Therapeutics' shares are currently sold short. Learn More on Dermata Therapeutics' current short interest. What is a good short interest ratio for Dermata Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DRMA shares currently have a short interest ratio of 1.0. Learn More on Dermata Therapeutics's short interest ratio. What is a good short interest percentage for Dermata Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.28% of Dermata Therapeutics' floating shares are currently sold short. Is Dermata Therapeutics' short interest increasing or decreasing? Dermata Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 80,400 shares, an increase of 3.6% from the previous total of 77,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Dermata Therapeutics' float size? Dermata Therapeutics currently has issued a total of 6,660,000 shares. Some of Dermata Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Dermata Therapeutics currently has a public float of 6,260,000 shares. How does Dermata Therapeutics' short interest compare to its competitors? 1.28% of Dermata Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Dermata Therapeutics: Salarius Pharmaceuticals, Inc. (1.65%), CNS Pharmaceuticals, Inc. (0.31%), CohBar, Inc. (0.59%), 60 Degrees Pharmaceuticals, Inc. (1.31%), Sonoma Pharmaceuticals, Inc. (0.30%), Galmed Pharmaceuticals Ltd. (1.49%), Bio-Path Holdings, Inc. (2.85%), Notable Labs, Ltd. (0.08%), Clearmind Medicine Inc. (5.51%), Avenue Therapeutics, Inc. (3.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Dermata Therapeutics stock? Short selling DRMA is an investing strategy that aims to generate trading profit from Dermata Therapeutics as its price is falling. DRMA shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dermata Therapeutics? A short squeeze for Dermata Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DRMA, which in turn drives the price of the stock up even further. How often is Dermata Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DRMA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Salarius Pharmaceuticals Short Squeeze CNS Pharmaceuticals Short Squeeze CohBar Short Squeeze 60 Degrees Pharmaceuticals Short Squeeze Sonoma Pharmaceuticals Short Squeeze Galmed Pharmaceuticals Short Squeeze Bio-Path Short Squeeze Notable Labs Short Squeeze Clearmind Medicine Short Squeeze Avenue Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DRMA) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe Crypto 9-5 Escape PlanCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics